PHARMA TRENDS EXPO & SUMMIT 2025
The Pharma Trends Expo & Summit 2025 is a globally recognized platform that convenes pharmaceutical professionals, policymakers, scientific innovators, and healthcare leaders to accelerate the advancement of the pharmaceutical industry in a rapidly evolving global health environment.
In the wake of global health disruptions, rising chronic disease burdens, and the increasing pressure for sustainable, patient-centric care models, the summit offers actionable strategies and cutting-edge insights that are driving transformation across the entire pharmaceutical value chain.
Global PHT 2023 is “ Innovation, Advanced Technology, Current Challenges & Opportunities in Pharma & Healthcare Industry”. The program has already shaped up to be excellent, and the networking opportunities will be indeed outstanding and I look forward to learning the latest results from top industrial, government, and academic scientists on these topics and everything else that is presented. We are indeed in a time of great innovation in materials chemistry, so come and enjoy the research, and report your results. The program has already shaped up to be excellent, and the networking opportunities will be indeed outstanding. “
Chairman
Dr. Jagadeesh Babu Rangisetty
Chairman – Global PHT Expo & Summit-2023
CEO – Biophore India Pharmaceuticals Pvt. Ltd.
Hyderabad, Telangana, India
” Innovation is the need of the day and the disconnect
between industry and academia has to go away. “
Chief Guest
Dr. Y. K. Gupta
President – AIIMS, Bhopal, President – AIIMS, Samba
Jammu, Principal Adviser (Project), \THSTI – DBT, GOI, Chairman – Board
of Directors, BOBCOI, DBT, GOI Member General Body & Govt. Body –
National Dope, Testing Lab, GOI Bhopal
Delhi NCR, India
” These conferences are the need of the hour so that we can meet, interact, and exchange ideas and thoughts with people whom we consider as the pioneer in one or the other field or they are the innovators in their respective fields. “
Convenor
Dr. Upendra Nagaich
Convenor – Global PHT Expo & Summit – 2023
National Secretary – Society of Pharmaceutical
Education & Research (SPER)
Delhi NCR, India
Based on my experience I see that we have a lot of money and great opportunities in India, but we don’t want to take the risk. Unless you take a risk, you cannot innovate.
Chief Strategic Advisor
Dr. Dhileep Krishnamurthy
Chief Strategic Advisor –
Global PHT Expo & Summit 2023
Executive Advisor for Biotech,
CRAMS and Generic Industries in
USA, India & China
Anytime nature hits you it gives you enough warning in advance. There is no point in facing and then reinventing a medicine on the spot that’s tough and that’s what we went through. For some reason, we did not pay attention when the SARS virus hit Singapore and at that time, we should have continued the research so that we could have been better at it globally. So, people have neglected it that’s what I would say.
Chairman – Technology
Mr. Mekala Rao
Chairman – Technology
Global PHT Expo & Summit-2023
President – Atachi Systems
California, USA
His views on the Impact of Process Chemistry in Healthcare Sciences. As a renowned chemist, Dr. Senanayake discussed the need to adopt green chemistry in the process of drug development for cost reduction, timely innovation, and generating less waste
than the standard process. The expertise and capabilities of TCG GreenChem were also highlighted along with TCG’s Continuous Flow Chemistry Lab (CFL) Platforms.
Keynote Speaker
Dr. Chris Senanayake
CEO TCG Green Chem
CSO TCG Life Sciences
The world before and after the pandemic is not the same. We have seen a lot of challenges like a shortage of medication due to changes in demand. It not only impacted the supply chain but also the manufacturing of some molecules that were to be on the market soon, but they were delayed due to the focus on the covid. I feel the pharmaceutical industry or even the countries or governments were not ready for such a huge pandemic. So, to summarise I hope that the future will be organized to manage such crisis.
Moderator
Dr. Adel Djalal
Managing Director – Alfa Diag, UAE
Dr. Joe presented on the Blockbuster Drug Januvia: An Innovators Perspective. Januvia is the FIC DPP-4 inh. class that received its FDA approval in Oct’2006 for T2D. Explaining the causes and consequences of elevated blood glucose, Dr. Joe showed the high throughput screening results received from Januvia for the treatment of the disease. He also included the award winning green chemistry of Januvia and a small explanation of acceleration
value for the development of the drug.
Keynote Speaker
Dr. Joe Armstrong
COO – TCG GreenChem, Inc.
Global Head of Business Development
US
Targeted Drugs for Cancer was the topic of Dr. Sumith’s talk. In giving a brief about cancer biology, he gave a comparative view of the conventional therapeutics, molecular-targeted therapeutics, and ligand-targeted therapeutics used for the treatment of cancer. Focusing on ligand-targeted therapeutics, Dr. Sumith highlighted different agents that have managed to reach clinical trials two of which had received FDA approval for the treatment of prostate cancer. Some results from the pre-clinical studies of Cytalux, EC0652/DUPA-SPECT, and EC1168/DUPA SMDC were also highlighted in the presentation.
Keynote Speaker
Dr. Sumith Kularatne
Executive VP of R&D on
Target Laboratories, LLC, USA
past Session on Pharma Trends
Session on - Global Pharmacovigilance & Indian Perspectives
Panellists: Dr. Y Sridhar Reddy (Global Head – Pharmacovigilance Clinical Development and Medical Affairs, Hetero); Dr. Shubhadeep Debabrata Sinha (SVP, Medical Director & Head Hetero drugs); Dr.
Addepalli Veeranjaneyulu (Director of Research & Professor – Pharmacology – Dr. D.Y. Patil (Institute of Pharmaceutical Sciences
and Research); Dr. Shraddha Bhange (Medical Director EVERSANA)
Session on - Advanced Manufacturing Technologies
Panellists: Dr. Gurram Kishan (Founder & MD – Sravathi AI Technology Pvt. Ltd, India) Prof. Anil Kumar (Professor – IIT Bombay,
India).
Session on - Smart manufacturing of Biologics
Panelists: Prof. Anurag Rathore (Dept. of Chemical Engineering, IIT, India) Mr. Dharmesh Kharwar (Director- NCB Laboratories) Dr. Samir Vyas (Country GM -Agilent Technologies, India) Dr. Dilip
Sawhney (MD- Rockwell Automation, India) Mr. Sethu Madhavan (VP- BBIL SDN, India)
Session on - Chemistry in API Process Research and Development
Panellists: Dr. Rajender Leleti (CEO ARING/MANE Group, India) Dr. Gaurav Sharma (Director-Integral BioSciences, India) Dr. Shashikant (Head-CRD (GM)- Ind-Swift-Labs., India) Dr. Antony Melvin Crasto.
Session on - Current organizational sentiment in the healthcare and pharmaceutical industry |Policy reforms required in the sectors (HR FORUM)
Panellists: Dr. Vijayabhaskar Annapareddy Dr. Bala Prabhakar (Dean, Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management SVKM’s NMIMS, India) Dr. Indrashree Dusane (Hon.
Professor & Occupational Medicine Physician -RCOH Member of ICOH – SCOM & IAOH Training Faculty of AHA) Mr. Rohit Sharma
(Associate GM Greytip Software, India); Mr. Arun Yadav (Co-Founder – MacroHire, India).
Session on - Current Regulatory, QC, QA Trends
Panelists: Ms. Nyela Haidery (Head of Regulatory- Axis Healthcare Consultancy, UAE) Dr. Rupali Paranjape (Founder & CEO at Blue Ocean Compliance, India) Mr. Dharmesh Kharwar Dr. Mangesh Arvind Mantri (Head BD & Techno commercial Senior Advisor ANTSTAR Global, India)
Session on - Pharma Trends & Digital Transformation
Panellists: Mr. Jaweed Akhter Chowdhary (Practice Head -Samvardhana Motherson Health Solution Ltd, India) Dr. Varma S. Rudraraju (CEO-Aizant Pharma, India) Mr. Mekala Rao Mr.Mohammad Shahbaz Alam (Founder & CEO – Shahbaz Pharma, India) Dr. Subrahmanyam Vangala (CEO & Founder – Reagene Biosciences, India).
Session on - Industry Academia Interaction: A Pivotal Platform For Promoting Skills In Higher Educational Institutions (HEI)
Panellists: Prof. Sarika Gupta (Staff Scientist – National Institute of Immunology, India) Dr. Rakesh Somani (Professor & Principal – Dy Patil University President – APTI, India) Dr. Vir Vikram Sharma (Principal – School of Pharmaceutical Sciences, Department of Pharmacology CT University, India) Dr. Shamim Bandey (Sr. Assistant professor Department of Zoology Higher Education Dept. J&K Government, India) Dr. Harvinder Popli (Director – DPSRU, India) Dr. Rupali Tashgaonkar (Principal,Tashgaonkar College, Mumbai, India) Dr. Vimal Rarh (Joint Director – Guru Angad Dev Teaching Learning Centre of MHRD Deputy Director – Centre for E-learning, SGTB Khalsa College, India) Dr. Rajni Jha
OUR PAST COMMITTEE
OUR PAST SPEAKERS
